Pękala A, Aebisher D, Pardak P, Filip R. Efficacy and safety of biosimilar IFX (CT-P13) and adalimumab in patients with active fistulizing perianal Crohn’s disease naďve to anti-TNF therapy: preliminary results from the POLIBD study. Eur J Clin Exp Med [Internet]. 2019 Mar. 30 [cited 2026 Jan. 18];17(1):12–15. Available from: https://journals.ur.edu.pl/ejcem/article/view/11746